We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Jefferson Health & Sarah Cannon Research Institute Announce Cancer Drug Development Collaboration

News   Jun 04, 2018 | Original story from Sarah Cannon

 
Jefferson Health & Sarah Cannon Research Institute Announce Cancer Drug Development Collaboration

Credit: Sarah Cannon

 
 
 

RELATED ARTICLES

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

3D Mammography Significantly Reduces Breast Biopsy Rates

News

The use of digital breast tomosynthesis (DBT), also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study published in the journal Radiology.

READ MORE

The Key to a Common Cancer Pathway

News

A team reports the discovery of an unexpected regulator of the critical protein p53, opening the door to the development of drugs that could target it.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE